Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2025-12-26 @ 3:43 AM
Study NCT ID:
NCT00601718
Status:
COMPLETED
Last Update Posted:
2017-05-25
First Post:
2008-01-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12
Start Date Type:
None
Primary Completion Date:
2010-06
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2008-01-24
First Submit QC Date:
None
Study First Post Date:
2008-01-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-17
Results First Submit QC Date:
None
Results First Post Date:
2017-05-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-17
Last Update Post Date:
2017-05-25
Last Update Post Date Type:
ACTUAL